{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:05:59Z","timestamp":1793739959788,"version":"4.6.1"},"reference-count":316,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cyclin-dependent kinases (CDKs) regulate cell division at multiple levels. Aberrant proliferation induced by abnormal cell cycle is a hallmark of cancer. Over the past few decades, several drugs that inhibit CDK activity have been created to stop the development of cancer cells. The third generation of selective CDK4\/6 inhibition has proceeded into clinical trials for a range of cancers and is quickly becoming the backbone of contemporary cancer therapy. Non-coding RNAs, or ncRNAs, do not encode proteins. Many studies have demonstrated the involvement of ncRNAs in the regulation of the cell cycle and their abnormal expression in cancer. By interacting with important cell cycle regulators, preclinical studies have demonstrated that ncRNAs may decrease or increase the treatment outcome of CDK4\/6 inhibition. As a result, cell cycle-associated ncRNAs may act as predictors of CDK4\/6 inhibition efficacy and perhaps present novel candidates for tumor therapy and diagnosis.<\/jats:p>","DOI":"10.3390\/ijms24108939","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:09:44Z","timestamp":1684397384000},"page":"8939","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4\/6 Inhibition"],"prefix":"10.3390","volume":"24","author":[{"given":"Qingyi","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.tibs.2022.06.007","article-title":"Coordinating gene expression during the cell cycle","volume":"47","author":"Fischer","year":"2022","journal-title":"Trends Biochem. Sci."},{"key":"ref_2","first-page":"E3837","article-title":"Negative regulator of E2F transcription factors links cell cycle checkpoint and DNA damage repair","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.matbio.2013.10.011","article-title":"Signalling pathways linking integrins with cell cycle progression","volume":"34","author":"Streuli","year":"2014","journal-title":"Matrix Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1158\/2159-8290.CD-15-0894","article-title":"Targeting CDK4 and CDK6: From Discovery to Therapy","volume":"6","author":"Sherr","year":"2016","journal-title":"Cancer Discov."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ccell.2017.11.006","article-title":"Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor Abemaciclib","volume":"32","author":"Gong","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.tcb.2018.07.002","article-title":"CDK4\/6 Inhibition in Cancer: Beyond Cell Cycle Arrest","volume":"28","author":"Goel","year":"2018","journal-title":"Trends Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrclinonc.2016.26","article-title":"Treating cancer with selective CDK4\/6 inhibitors","volume":"13","author":"Finn","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1505270","article-title":"Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer","volume":"373","author":"Turner","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMoa2114663","article-title":"Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer","volume":"386","author":"Hortobagyi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1200\/JCO.20.02514","article-title":"Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)","volume":"38","author":"Johnston","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"104640","DOI":"10.1016\/j.yexmp.2021.104640","article-title":"New insights into long non-coding RNAs in breast cancer: Biological functions and therapeutic prospects","volume":"120","author":"Wang","year":"2021","journal-title":"Exp. Mol. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41556-022-00880-5","article-title":"Exploring the expanding universe of small RNAs","volume":"24","author":"Shi","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The Role of Non-coding RNAs in Oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrm.2017.104","article-title":"The functions and unique features of long intergenic non-coding RNA","volume":"19","author":"Ransohoff","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","article-title":"Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches","volume":"96","author":"Beermann","year":"2016","journal-title":"Physiol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11427-020-1700-9","article-title":"Non-coding RNAs: The new central dogma of cancer biology","volume":"64","author":"Saw","year":"2021","journal-title":"Sci. China Life Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cels.2016.01.001","article-title":"A Dynamical Framework for the All-or-None G1\/S Transition","volume":"2","author":"Barr","year":"2016","journal-title":"Cell Syst."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1093\/nar\/gkaa1002","article-title":"A unified model for the G1\/S cell cycle transition","volume":"48","author":"Hume","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1534-5807(04)00067-X","article-title":"Cell cycle development","volume":"6","author":"Coffman","year":"2004","journal-title":"Dev. Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","article-title":"Cell cycle regulation: p53-p21-RB signaling","volume":"29","author":"Engeland","year":"2022","journal-title":"Cell Death Differ."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.trecan.2019.03.005","article-title":"Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy","volume":"5","author":"Knudsen","year":"2019","journal-title":"Trends Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1101\/gad.1116703","article-title":"Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F\/RB pathway","volume":"17","author":"Dimova","year":"2003","journal-title":"Genes. Dev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.cell.2016.11.034","article-title":"CDK Substrate Phosphorylation and Ordering the Cell Cycle","volume":"167","author":"Swaffer","year":"2016","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrm3629","article-title":"Control of cell cycle transcription during G1 and S phases","volume":"14","author":"Bertoli","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nature06955","article-title":"Global control of cell-cycle transcription by coupled CDK and network oscillators","volume":"453","author":"Orlando","year":"2008","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"20608","DOI":"10.1074\/jbc.271.34.20608","article-title":"Cyclin D1 expression is regulated positively by the p42\/p44MAPK and negatively by the p38\/HOGMAPK pathway","volume":"271","author":"Lavoie","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1038\/sj.onc.1208613","article-title":"Cyclin E in normal and neoplastic cell cycles","volume":"24","author":"Hwang","year":"2005","journal-title":"Oncogene"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1083\/jcb.201211019","article-title":"The spindle checkpoint, APC\/C(Cdc20), and APC\/C(Cdh1) play distinct roles in connecting mitosis to S phase","volume":"201","author":"Clijsters","year":"2013","journal-title":"J. Cell Biol."},{"key":"ref_29","first-page":"43","article-title":"The INK4 family of CDK inhibitors","volume":"227","author":"Carnero","year":"1998","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(00)00092-5","article-title":"Cell-cycle inhibitors: Three families united by a common cause","volume":"247","author":"Vidal","year":"2000","journal-title":"Gene"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tcb.2021.01.010","article-title":"New Insights into CDK Regulators: Novel Opportunities for Cancer Therapy","volume":"31","author":"Bury","year":"2021","journal-title":"Trends Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1128\/MCB.15.5.2682","article-title":"Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4","volume":"15","author":"Chan","year":"1995","journal-title":"Mol. Cell Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/371257a0","article-title":"p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest","volume":"371","author":"Hannon","year":"1994","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1101\/gad.8.24.2939","article-title":"Growth suppression by p18, a p16INK4\/MTS1- and p14INK4B\/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function","volume":"8","author":"Guan","year":"1994","journal-title":"Genes. Dev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1128\/MCB.15.5.2672","article-title":"Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6","volume":"15","author":"Hirai","year":"1995","journal-title":"Mol. Cell Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1101\/gad.851100","article-title":"Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors","volume":"14","author":"Jeffrey","year":"2000","journal-title":"Genes. Dev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","article-title":"A cell cycle regulator potentially involved in genesis of many tumor types","volume":"264","author":"Kamb","year":"1994","journal-title":"Science"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1038\/sj.onc.1202998","article-title":"The INK4 family of cell cycle inhibitors in cancer","volume":"18","author":"Roussel","year":"1999","journal-title":"Oncogene"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0092-8674(00)81079-X","article-title":"Role of the INK4a locus in tumor suppression and cell mortality","volume":"85","author":"Serrano","year":"1996","journal-title":"Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cell.2006.10.003","article-title":"The regulation of INK4\/ARF in cancer and aging","volume":"127","author":"Kim","year":"2006","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: Positive and negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes. Dev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.devcel.2008.01.013","article-title":"CDK inhibitors: Cell cycle regulators and beyond","volume":"14","author":"Besson","year":"2008","journal-title":"Dev. Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1101\/gad.12.24.3882","article-title":"Complete inhibition of Cdk\/cyclin by one molecule of p21(Cip1)","volume":"12","author":"Hengst","year":"1998","journal-title":"Genes. Dev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nsmb746","article-title":"p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding","volume":"11","author":"Lacy","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4161\/cc.7.7.5637","article-title":"Switching cyclin D-Cdk4 kinase activity on and off","volume":"7","author":"Blain","year":"2008","journal-title":"Cell Cycle"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Bencivenga, D., Stampone, E., Roberti, D., Della Ragione, F., and Borriello, A. (2021). p27(Kip1), an Intrinsically Unstructured Protein with Scaffold Properties. Cells, 10.","DOI":"10.3390\/cells10092254"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0092-8674(95)90039-X","article-title":"Mice lacking p21CIP1\/WAF1 undergo normal development, but are defective in G1 checkpoint control","volume":"82","author":"Deng","year":"1995","journal-title":"Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","article-title":"The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases","volume":"75","author":"Harper","year":"1993","journal-title":"Cell"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"p21 in cancer: Intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.tips.2016.06.006","article-title":"Targeting WEE1 Kinase in Cancer","volume":"37","author":"Matheson","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1158\/1078-0432.CCR-17-0520","article-title":"Molecular Pathways: Targeting the Protein Kinase Wee1 in Cancer","volume":"23","author":"Geenen","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41580-021-00447-6","article-title":"Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics","volume":"23","author":"Nojima","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nsmb.2480","article-title":"Structure and function of long noncoding RNAs in epigenetic regulation","volume":"20","author":"Mercer","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2009.02.006","article-title":"Evolution and functions of long noncoding RNAs","volume":"136","author":"Ponting","year":"2009","journal-title":"Cell"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-10-5203-3_1","article-title":"History, Discovery, and Classification of lncRNAs","volume":"Volume 1008","author":"Jarroux","year":"2017","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s10038-006-0070-9","article-title":"Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction","volume":"51","author":"Ishii","year":"2006","journal-title":"J. Hum. Genet."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41584-021-00687-y","article-title":"The non-coding RNA interactome in joint health and disease","volume":"17","author":"Ali","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_59","first-page":"558","article-title":"Long non-coding RNAs and complex diseases: From experimental results to computational models","volume":"18","author":"Chen","year":"2017","journal-title":"Brief. Bioinform."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature23451","article-title":"Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood","volume":"548","author":"Joung","year":"2017","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fimmu.2019.00420","article-title":"Disease-Associated SNPs in Inflammation-Related lncRNAs","volume":"10","author":"Ghosh","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Gao, P., and Wei, G.H. (2017). Genomic Insight into the Role of lncRNA in Cancer Susceptibility. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18061239"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0168-9525(02)02717-8","article-title":"X-chromosome inactivation: Closing in on proteins that bind Xist RNA","volume":"18","author":"Brockdorff","year":"2002","journal-title":"Trends Genet."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"ra8","DOI":"10.1126\/scisignal.2000568","article-title":"Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor","volume":"3","author":"Kino","year":"2010","journal-title":"Sci. Signal."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.celrep.2015.03.008","article-title":"The lncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression","volume":"11","author":"Jiang","year":"2015","journal-title":"Cell Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1126\/science.1228110","article-title":"Airn transcriptional overlap, but not its lncRNA products, induces imprinted Igf2r silencing","volume":"338","author":"Latos","year":"2012","journal-title":"Science"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.molcel.2008.07.023","article-title":"The LPS-induced transcriptional upregulation of the chicken lysozyme locus involves CTCF eviction and noncoding RNA transcription","volume":"32","author":"Lefevre","year":"2008","journal-title":"Mol. Cell"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"16410","DOI":"10.1073\/pnas.1904108116","article-title":"Regulation of CCL2 expression in human vascular endothelial cells by a neighboring divergently transcribed long noncoding RNA","volume":"116","author":"Khyzha","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1631\/jzus.B1900422","article-title":"Roles of PTBP1 in alternative splicing, glycolysis, and oncogensis","volume":"21","author":"Zhu","year":"2020","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"D1295","DOI":"10.1093\/nar\/gkab1035","article-title":"lncRNAfunc: A knowledgebase of lncRNA function in human cancer","volume":"50","author":"Yang","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s11427-013-4553-6","article-title":"Function of lncRNAs and approaches to lncRNA-protein interactions","volume":"56","author":"Zhu","year":"2013","journal-title":"Sci. China Life Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"11645","DOI":"10.1093\/nar\/gkaa919","article-title":"TPR is required for the efficient nuclear export of mRNAs and lncRNAs from short and intron-poor genes","volume":"48","author":"Lee","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1261\/rna.068288.118","article-title":"Predictive models of subcellular localization of long RNAs","volume":"25","author":"Zuckerman","year":"2019","journal-title":"RNA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"D231","DOI":"10.1093\/nar\/gkv1270","article-title":"DIANA-LncBase v2: Indexing microRNA targets on non-coding transcripts","volume":"44","author":"Paraskevopoulou","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fcell.2019.00350","article-title":"Long Non-coding RNA LINC-PINT Suppresses Cell Proliferation and Migration of Melanoma via Recruiting EZH2","volume":"7","author":"Xu","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e1705","DOI":"10.1002\/wrna.1705","article-title":"PINTology: A short history of the lncRNA LINC-PINT in different diseases","volume":"13","author":"Bukhari","year":"2022","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/hep.24563","article-title":"Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans","volume":"54","author":"Yang","year":"2011","journal-title":"Hepatology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1158\/0008-5472.CAN-06-2004","article-title":"Characterization of a germ-line deletion, including the entire INK4\/ARF locus, in a melanoma-neural system tumor family: Identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF","volume":"67","author":"Pasmant","year":"2007","journal-title":"Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.molcel.2010.03.021","article-title":"Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a","volume":"38","author":"Yap","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/onc.2010.568","article-title":"Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene","volume":"30","author":"Kotake","year":"2011","journal-title":"Oncogene"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40659-022-00411-4","article-title":"Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis","volume":"56","author":"Zangouei","year":"2023","journal-title":"Biol. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1533033820948880","DOI":"10.1177\/1533033820948880","article-title":"Down-Regulation of TMPO-AS1 Induces Apoptosis in Lung Carcinoma Cells by Regulating miR-143-3p\/CDK1 Axis","volume":"20","author":"Li","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Xue, J., Song, Y., Xu, W., and Zhu, Y. (2022). The CDK1-Related lncRNA and CXCL8 Mediated Immune Resistance in Lung Adenocarcinoma. Cells, 11.","DOI":"10.3390\/cells11172688"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"S257","DOI":"10.1177\/09603271211038744","article-title":"Long non-coding RNA LINC00630 facilitates hepatocellular carcinoma progression through recruiting transcription factor E2F1 to up-regulate cyclin-dependent kinase 2 expression","volume":"40","author":"Kang","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"7326","DOI":"10.21037\/jtd-20-3378","article-title":"Low expression of long non-coding RNA ARAP1-AS1 can inhibit lung cancer proliferation by inducing G0\/G1 cell cycle organization","volume":"12","author":"Tao","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/2211-5463.13140","article-title":"The lncRNA ALMS1-IT1 may promote malignant progression of lung adenocarcinoma via AVL9-mediated activation of the cyclin-dependent kinase pathway","volume":"11","author":"Luan","year":"2021","journal-title":"Febs Open Bio"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2147\/OTT.S236158","article-title":"A Novel lncRNA ENST00000512916 Facilitates Cell Proliferation, Migration and Cell Cycle Progression in Ameloblastoma","volume":"13","author":"Sun","year":"2020","journal-title":"Oncotargets Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1007\/s13277-015-4151-2","article-title":"Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163","volume":"37","author":"Su","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_89","first-page":"39","article-title":"Knockdown of TPT1-AS1 inhibits cell proliferation, cell cycle G1\/S transition, and epithelial-mesenchymal transition in gastric cancer","volume":"21","author":"Tang","year":"2021","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12032-014-0042-4","article-title":"Increased expression of long noncoding RNA ABHD11-AS1 in gastric cancer and its clinical significance","volume":"31","author":"Lin","year":"2014","journal-title":"Med. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-017-0709-5","article-title":"Role of the lncRNA ABHD11-AS(1) in the tumorigenesis and progression of epithelial ovarian cancer through targeted regulation of RhoC","volume":"16","author":"Wu","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"28176","DOI":"10.18632\/oncotarget.14945","article-title":"Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1111\/jcmm.13675","article-title":"LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1","volume":"22","author":"Liu","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2020.12.026","article-title":"LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3","volume":"182","author":"Sharma","year":"2021","journal-title":"Biochimie"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.2147\/CMAR.S197673","article-title":"lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN\/AKT\/GSK-3\u03b2 axis in hepatocellular carcinoma","volume":"11","author":"Wang","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1038\/emboj.2012.292","article-title":"Long non-coding RNA gadd7 interacts with TDP-43 and regulates Cdk6 mRNA decay","volume":"31","author":"Liu","year":"2012","journal-title":"EMBO J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/nar\/24.9.1589","article-title":"A novel DNA damage-inducible transcript, gadd7, inhibits cell growth, but lacks a protein product","volume":"24","author":"Hollander","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"113701","DOI":"10.18632\/oncotarget.22555","article-title":"The lncRNA XIST interacts with miR-140\/miR-124\/iASPP axis to promote pancreatic carcinoma growth","volume":"8","author":"Liang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/JHC.S306484","article-title":"LncRNA-CCDC144NL-AS1 Promotes the Development of Hepatocellular Carcinoma by Inducing WDR5 Expression via Sponging miR-940","volume":"8","author":"Zhang","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12943-020-01210-9","article-title":"LncRNA TROJAN promotes proliferation and resistance to CDK4\/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer","volume":"19","author":"Jin","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s13046-019-1371-0","article-title":"Modulating lncRNA SNHG15\/CDK6\/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme","volume":"38","author":"Li","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature02873","article-title":"Mechanisms of gene silencing by double-stranded RNA","volume":"431","author":"Meister","year":"2004","journal-title":"Nature"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrc2619","article-title":"MicroRNAs--the micro steering wheel of tumour metastases","volume":"9","author":"Nicoloso","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs\u2014microRNAs with a role in cancer","volume":"6","author":"Slack","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1093\/emboj\/cdf476","article-title":"MicroRNA maturation: Stepwise processing and subcellular localization","volume":"21","author":"Lee","year":"2002","journal-title":"EMBO J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1101\/gad.1158803","article-title":"Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs","volume":"17","author":"Yi","year":"2003","journal-title":"Genes. Dev."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nsmb.2296","article-title":"The mechanics of miRNA-mediated gene silencing: A look under the hood of miRISC","volume":"19","author":"Fabian","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.cell.2007.10.032","article-title":"Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression","volume":"131","author":"Diederichs","year":"2007","journal-title":"Cell"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.3748\/wjg.v19.i20.2985","article-title":"Role of microRNAs in the immune system, inflammation and cancer","volume":"19","author":"Raisch","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1101\/sqb.2006.71.039","article-title":"Deep conservation of microRNA-target relationships and 3\u2019UTR motifs in vertebrates, flies, and nematodes","volume":"71","author":"Chen","year":"2006","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nature07299","article-title":"MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation","volume":"455","author":"Tay","year":"2008","journal-title":"Nature"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.4161\/15384047.2014.955442","article-title":"miRNA biogenesis: Biological impact in the development of cancer","volume":"15","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrm2621","article-title":"MicroRNAs: Key regulators of stem cells","volume":"10","author":"Gangaraju","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/onc.2008.474","article-title":"Role of miR-143 targeting KRAS in colorectal tumorigenesis","volume":"28","author":"Chen","year":"2009","journal-title":"Oncogene"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/hep.23818","article-title":"Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development","volume":"52","author":"Xu","year":"2010","journal-title":"Hepatology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1021\/ja910275u","article-title":"Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma","volume":"132","author":"Young","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1074\/jbc.M609383200","article-title":"Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b","volume":"282","author":"Scott","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1618","article-title":"Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model","volume":"28","author":"Ma","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"18121","DOI":"10.1074\/jbc.M113.478560","article-title":"c-MYC-regulated miR-23a\/24-2\/27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2","volume":"288","author":"Li","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"11400","DOI":"10.1073\/pnas.0704372104","article-title":"Let-7 expression defines two differentiation stages of cancer","volume":"104","author":"Shell","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3892\/ol.2012.841","article-title":"miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor status","volume":"4","author":"Lu","year":"2012","journal-title":"Oncol. Lett."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.gene.2012.12.103","article-title":"MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer","volume":"518","author":"Deng","year":"2013","journal-title":"Gene"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hep.22919","article-title":"MicroRNA-195 suppresses tumorigenicity and regulates G1\/S transition of human hepatocellular carcinoma cells","volume":"50","author":"Xu","year":"2009","journal-title":"Hepatology"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/cm.20517","article-title":"Regulation of \u03b2-tubulin isotypes by micro-RNA 100 in MCF7 breast cancer cells","volume":"68","author":"Lobert","year":"2011","journal-title":"Cytoskeleton"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"11650","DOI":"10.1038\/srep11650","article-title":"The role of miR-100 in regulating apoptosis of breast cancer cells","volume":"5","author":"Gong","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbrc.2019.03.082","article-title":"MiR-365 enhances the radiosensitivity of non-small cell lung cancer cells through targeting CDC25A","volume":"512","author":"Li","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcb.24841","article-title":"MicroRNA-365 inhibits the proliferation of vascular smooth muscle cells by targeting cyclin D1","volume":"115","author":"Kim","year":"2014","journal-title":"J. Cell. Biochem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3892\/ijo.2013.2034","article-title":"MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer","volume":"43","author":"Luo","year":"2013","journal-title":"Int. J. Oncol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm.1880","article-title":"The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities","volume":"14","author":"Bonci","year":"2008","journal-title":"Nat. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3892\/or.2012.1995","article-title":"miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma","volume":"28","author":"Cai","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1476-4598-10-55","article-title":"miR-34a and miR-15a\/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner","volume":"10","author":"Bandi","year":"2011","journal-title":"Mol. Cancer"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/cr.2008.45","article-title":"MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth","volume":"18","author":"Schultz","year":"2008","journal-title":"Cell Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1158\/0008-5472.CAN-07-1083","article-title":"The let-7 microRNA represses cell proliferation pathways in human cells","volume":"67","author":"Johnson","year":"2007","journal-title":"Cancer Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3389\/fphar.2018.01544","article-title":"Niclosamide Induces Cell Cycle Arrest in G1 Phase in Head and Neck Squamous Cell Carcinoma Through Let-7d\/CDC34 Axis","volume":"9","author":"Han","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_139","first-page":"495","article-title":"let-7 and miR-17 promote self-renewal and drive gefitinib resistance in non-small cell lung cancer","volume":"42","author":"Yin","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbrc.2013.12.095","article-title":"MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells","volume":"443","author":"Zhang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Sanchez, N., Gallagher, M., Lao, N., Gallagher, C., Clarke, C., Doolan, P., Aherne, S., Blanco, A., Meleady, P., and Clynes, M. (2013). MiR-7 triggers cell cycle arrest at the G1\/S transition by targeting multiple genes including Skp2 and Psme3. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065671"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.toxlet.2018.05.040","article-title":"miR-19 targeting of PTEN mediates butyl benzyl phthalate-induced proliferation in both ER(+) and ER(-) breast cancer cells","volume":"295","author":"Wu","year":"2018","journal-title":"Toxicol. Lett."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1474-9726.2010.00549.x","article-title":"miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging","volume":"9","author":"Hackl","year":"2010","journal-title":"Aging Cell"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1083\/jcb.200801079","article-title":"A cyclin D1\/microRNA 17\/20 regulatory feedback loop in control of breast cancer cell proliferation","volume":"182","author":"Yu","year":"2008","journal-title":"J. Cell Biol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/jcp.25051","article-title":"The Effects of miR-20a on p21: Two Mechanisms Blocking Growth Arrest in TGF-\u03b2-Responsive Colon Carcinoma","volume":"230","author":"Sokolova","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1074\/jbc.M608939200","article-title":"An E2F\/miR-20a autoregulatory feedback loop","volume":"282","author":"Sylvestre","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e2000383","DOI":"10.1002\/mnfr.202000383","article-title":"Saturated Fatty Acids Promote Hepatocytic Senecence through Regulation of miR-34a\/Cyclin-Dependent Kinase 6","volume":"64","author":"Qin","year":"2020","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/mt.2013.148","article-title":"TP53-independent function of miR-34a via HDAC1 and p21(CIP1\/WAF1.)","volume":"21","author":"Zhao","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1158\/0008-5472.CAN-08-4025","article-title":"Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia","volume":"69","author":"Agirre","year":"2009","journal-title":"Cancer Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/art.24475","article-title":"MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"60","author":"Nakamachi","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"i88","DOI":"10.1136\/ard.2010.138669","article-title":"miR-124a as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis","volume":"70","author":"Kawano","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/hep.26101","article-title":"Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.brainres.2009.11.056","article-title":"MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation","volume":"1312","author":"Shi","year":"2010","journal-title":"Brain Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/ijc.25509","article-title":"MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3","volume":"128","author":"Huang","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/pros.23156","article-title":"miR-24 regulates CDKN1B\/p27 expression in prostate cancer","volume":"76","author":"Lynch","year":"2016","journal-title":"Prostate"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1158\/0008-5472.CAN-10-1850","article-title":"MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2","volume":"71","author":"Lu","year":"2011","journal-title":"Cancer Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1089\/scd.2016.0203","article-title":"miR-26a Mediates Adipogenesis of Amniotic Fluid Mesenchymal Stem\/Stromal Cells via PTEN, Cyclin E1, and CDK6","volume":"26","author":"Trohatou","year":"2017","journal-title":"Stem Cells Dev."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/mt.2011.64","article-title":"Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways","volume":"19","author":"Chen","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4161\/15384047.2014.987523","article-title":"MiR-101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2","volume":"16","author":"Zhou","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12967-015-0626-6","article-title":"MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8","volume":"13","author":"Li","year":"2015","journal-title":"J. Transl. Med."},{"key":"ref_161","first-page":"1754","article-title":"miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4\/6 pathway","volume":"46","author":"Shang","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/acel.12404","article-title":"CBX7 and miR-9 are part of an autoregulatory loop controlling p16(INK) (4a)","volume":"14","author":"Brookes","year":"2015","journal-title":"Aging Cell"},{"key":"ref_163","first-page":"1921","article-title":"miR-9 depletion suppresses the proliferation of osteosarcoma cells by targeting p16","volume":"54","author":"Gao","year":"2019","journal-title":"Int. J. Oncol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.3892\/ol.2015.3068","article-title":"miR-218 inhibits the proliferation of glioma U87 cells through the inactivation of the CDK6\/cyclin D1\/p21(Cip1\/Waf1) pathway","volume":"9","author":"Jun","year":"2015","journal-title":"Oncol. Lett."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.canlet.2017.06.006","article-title":"miR-218 suppresses gastric cancer cell cycle progression through the CDK6\/Cyclin D1\/E2F1 axis in a feedback loop","volume":"403","author":"Deng","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4161\/cbt.7.2.5297","article-title":"miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer","volume":"7","author":"Giannakakis","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s41440-022-00884-6","article-title":"LncRNA Rian reduces cardiomyocyte pyroptosis and alleviates myocardial ischemia-reperfusion injury by regulating by the miR-17-5p\/CCND1 axis","volume":"45","author":"Kang","year":"2022","journal-title":"Hypertens. Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2147\/CMAR.S298236","article-title":"Silencing of LncRNA SNHG16 Downregulates Cyclin D1 (CCND1) to Abrogate Malignant Phenotypes in Oral Squamous Cell Carcinoma (OSCC) Through Upregulating miR-17-5p","volume":"13","author":"Wang","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/gb-2008-9-8-r127","article-title":"The miR-17-5p microRNA is a key regulator of the G1\/S phase cell cycle transition","volume":"9","author":"Cloonan","year":"2008","journal-title":"Genome Biol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/onc.2008.372","article-title":"miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression","volume":"28","author":"Pickering","year":"2009","journal-title":"Oncogene"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","article-title":"c-Myc-regulated microRNAs modulate E2F1 expression","volume":"435","author":"Wentzel","year":"2005","journal-title":"Nature"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Trompeter, H.-I., Abbad, H., Iwaniuk, K.M., Hafner, M., Renwick, N., Tuschl, T., Schira, J., Mueller, H.W., and Wernet, P. (2011). MicroRNAs MiR-17, MiR-20a, and MiR-106b Act in Concert to Modulate E2F Activity on Cell Cycle Arrest during Neuronal Lineage Differentiation of USSC. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016138"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/path.5493","article-title":"SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors","volume":"252","author":"Xue","year":"2020","journal-title":"J. Pathol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1158\/0008-5472.CAN-09-3268","article-title":"The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression","volume":"70","author":"Wong","year":"2010","journal-title":"Cancer Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.0914900107","article-title":"Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia","volume":"107","author":"Mi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cancergen.2015.01.001","article-title":"WEE1 is a validated target of the microRNA miR-17-92 cluster in leukemia","volume":"208","author":"Brockway","year":"2015","journal-title":"Cancer Genet."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"457","DOI":"10.7150\/ijms.38832","article-title":"Oxidative Stress Down-Regulates MiR-20b-5p, MiR-106a-5p and E2F1 Expression to Suppress the G1\/S Transition of the Cell Cycle in Multipotent Stromal Cells","volume":"17","author":"Tai","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11060-013-1061-2","article-title":"Down-regulation of miR-106b suppresses the growth of human glioma cells","volume":"112","author":"Zhang","year":"2013","journal-title":"J. Neuro-Oncol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1053\/j.gastro.2009.02.002","article-title":"The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim","volume":"136","author":"Kan","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/path.2958","article-title":"MiR-17\/106b seed family regulates p21 in Hodgkin\u2019s lymphoma","volume":"225","author":"Gibcus","year":"2011","journal-title":"J. Pathol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1038\/onc.2009.192","article-title":"MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation","volume":"28","author":"Lee","year":"2009","journal-title":"Oncogene"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2010.05.082","article-title":"miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer","volume":"398","author":"Guo","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/cdd.2009.188","article-title":"E2F1-inducible microRNA 449a\/b suppresses cell proliferation and promotes apoptosis","volume":"17","author":"Pilarski","year":"2010","journal-title":"Cell Death Differ."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3892\/or.2013.2465","article-title":"miR-449b inhibits the proliferation of SW1116 colon cancer stem cells through downregulation of CCND1 and E2F3 expression","volume":"30","author":"Fang","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"19784","DOI":"10.1002\/jcb.29284","article-title":"Long noncoding RNA FOXD2-AS1 promotes glioma cell cycle progression and proliferation through the FOXD2-AS1\/miR-31\/CDK1 pathway","volume":"120","author":"Wang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.biopha.2018.12.102","article-title":"MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1)","volume":"111","author":"Li","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4161\/cc.9.3.10511","article-title":"The nuclear envelope can control gene expression and cell cycle progression via miRNA regulation","volume":"9","author":"Malhas","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1002\/cam4.5309","article-title":"miR-31\/QKI-5 axis facilitates cell cycle progression of non-small-cell lung cancer cells by interacting and regulating p21 and CDK4\/6 expressions","volume":"12","author":"Zhu","year":"2023","journal-title":"Cancer Med."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3892\/ijo.2015.3279","article-title":"miR-512-5p induces apoptosis and inhibits glycolysis by targeting p21 in non-small cell lung cancer cells","volume":"48","author":"Chu","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Wu, Z., Sun, H., Zeng, W., He, J., and Mao, X. (2012). Upregulation of MircoRNA-370 Induces Proliferation in Human Prostate Cancer Cells by Downregulating the Transcription Factor FOXO1. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045825"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/jcb.24613","article-title":"MicroRNA-212 inhibits proliferation of gastric cancer by directly repressing retinoblastoma binding protein 2","volume":"114","author":"Jiping","year":"2013","journal-title":"J. Cell Biochem."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/iub.1381","article-title":"miR-212\/132 downregulates SMAD2 expression to suppress the G1\/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells","volume":"67","author":"Zhao","year":"2015","journal-title":"IUBMB Life"},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Sun, M., Jin, F.Y., Xia, R., Kong, R., Li, J.H., Xu, T.P., Liu, Y.W., Zhang, E.B., Liu, X.H., and De, W. (2014). Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-319"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Delgir, S., Ilkhani, K., Safi, A., Rahmati, Y., Montazari, V., Zaynali-Khasraghi, Z., Seif, F., Bastami, M., and Alivand, M.R. (2021). The expression of miR-513c and miR-3163 was downregulated in tumor tissues compared with normal adjacent tissue of patients with breast cancer. BMC Med. Genom., 14.","DOI":"10.1186\/s12920-021-01029-3"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"29897","DOI":"10.1074\/jbc.M804612200","article-title":"MicroRNA-221\/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1","volume":"283","author":"Miller","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/cam4.412","article-title":"Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells","volume":"4","author":"Yamashita","year":"2015","journal-title":"Cancer Med."},{"key":"ref_197","first-page":"5215","article-title":"MiR-222 regulates the progression of oral squamous cell carcinoma by targeting CDKN1B","volume":"14","author":"Chen","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"627827","DOI":"10.3389\/fmolb.2020.627827","article-title":"LncRNA NEAT1 Promotes High Glucose-Induced Mesangial Cell Hypertrophy by Targeting miR-222-3p\/CDKN1B Axis","volume":"7","author":"Liao","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.7150\/jca.12546","article-title":"MicroRNA-222 Controls Human Pancreatic Cancer Cell Line Capan-2 Proliferation by P57 Targeting","volume":"6","author":"Zhao","year":"2015","journal-title":"J. Cancer"},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Im, W.R., Lee, H.-S., Lee, Y.-S., Lee, J.-S., Jang, H.-J., Kim, S.-Y., Park, J.-L., Lee, Y., Kim, M.S., and Lee, J.M. (2020). A Regulatory Noncoding RNA, nc886, Suppresses Esophageal Cancer by Inhibiting the AKT Pathway and Cell Cycle Progression. Cells, 9.","DOI":"10.3390\/cells9040801"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Fort, R.S., Math\u00f3, C., Geraldo, M.V., Ottati, M.C., Yamashita, A.S., Saito, K.C., Leite, K.R.M., M\u00e9ndez, M., Maedo, N., and M\u00e9ndez, L. (2018). Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4049-7"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood-2009-09-243147","article-title":"microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma","volume":"115","author":"Zhao","year":"2010","journal-title":"Blood"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41419-020-02980-2","article-title":"c-myc regulates the sensitivity of breast cancer cells to palbociclib via c-myc\/miR-29b-3p\/CDK6 axis","volume":"11","author":"Ji","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3892\/or.2021.8206","article-title":"miR-497\/MIR497HG inhibits glioma cell proliferation by targeting CCNE1 and the miR-588\/TUSC1 axis","volume":"46","author":"Ji","year":"2021","journal-title":"Oncol. Rep."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3324\/haematol.2018.195131","article-title":"miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells","volume":"104","author":"Quelen","year":"2019","journal-title":"Haematologica"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.2353\/ajpath.2010.091061","article-title":"MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma","volume":"176","author":"Chen","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Andrikopoulou, A., Shalit, A., Zografos, E., Koutsoukos, K., Korakiti, A.-M., Liontos, M., Dimopoulos, M.-A., and Zagouri, F. (2021). MicroRNAs as Potential Predictors of Response to CDK4\/6 Inhibitor Treatment. Cancers, 13.","DOI":"10.3390\/cancers13164114"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3892\/or.2020.7601","article-title":"miR-193b exhibits mutual interaction with MYC, and suppresses growth and metastasis of osteosarcoma","volume":"44","author":"Gao","year":"2020","journal-title":"Oncol. Rep."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/cam4.486","article-title":"Epigenetically altered miR-193b targets cyclin D1 in prostate cancer","volume":"4","author":"Kaukoniemi","year":"2015","journal-title":"Cancer Med."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.jid.2017.03.039","article-title":"MiR-200a Regulates CDK4\/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma","volume":"137","author":"Bustos","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/pcmr.12200","article-title":"MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D","volume":"27","author":"Georgantas","year":"2014","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Dahiya, N., Sherman-Baust, C.A., Wang, T.L., Davidson, B., Shih Ie, M., Zhang, Y., Wood, W., Becker, K.G., and Morin, P.J. (2008). MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002436"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.biopha.2013.03.013","article-title":"MiR-223\/Ect2\/p21 signaling regulates osteosarcoma cell cycle progression and proliferation","volume":"67","author":"Xu","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.18632\/oncotarget.1803","article-title":"Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner","volume":"5","author":"Armenia","year":"2014","journal-title":"Oncotarget"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/jim-2016-000233","article-title":"Restoration of microRNA-212 causes a G0\/G1 cell cycle arrest and apoptosis in adult T-cell leukemia\/lymphoma cells by repressing CCND3 expression","volume":"65","author":"Wang","year":"2017","journal-title":"J. Investig. Med."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1038\/ncomms3544","article-title":"Akt-p53-miR-365-cyclin D1\/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency","volume":"4","author":"Guo","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1093\/nar\/gkn522","article-title":"miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes","volume":"36","author":"Liu","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/MCB.02005-06","article-title":"Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression","volume":"27","author":"Linsley","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1073\/pnas.0914882107","article-title":"MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells","volume":"107","author":"Qin","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.febslet.2008.03.057","article-title":"Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest","volume":"582","author":"Sun","year":"2008","journal-title":"FEBS Lett."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.3748\/wjg.v25.i22.2752","article-title":"MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells","volume":"25","author":"Zheng","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.bbrc.2015.06.032","article-title":"RLIP76-dependent suppression of PI3K\/AKT\/Bcl-2 pathway by miR-101 induces apoptosis in prostate cancer","volume":"463","author":"Yang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3892\/ijmm.2016.2557","article-title":"MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer","volume":"37","author":"Guan","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.7150\/jca.33117","article-title":"MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2","volume":"10","author":"Li","year":"2019","journal-title":"J. Cancer"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"19678","DOI":"10.1073\/pnas.0811166106","article-title":"MicroRNA regulation of a cancer network: Consequences of the feedback loops involving miR-17-92, E2F, and Myc","volume":"105","author":"Aguda","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1128\/MCB.01372-09","article-title":"Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling","volume":"30","author":"Bueno","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Gruszka, R., Zakrzewski, K., Liberski, P.P., and Zakrzewska, M. (2021). mRNA and miRNA Expression Analyses of the MYC\/E2F\/miR-17-92 Network in the Most Common Pediatric Brain Tumors. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020543"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1101\/gad.1819009","article-title":"miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A","volume":"23","author":"Yang","year":"2009","journal-title":"Genes. Dev."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.molcel.2009.08.020","article-title":"miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to \u201cseedless\u201d 3\u2019UTR microRNA recognition elements","volume":"35","author":"Lal","year":"2009","journal-title":"Mol. Cell"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccell.2017.03.004","article-title":"Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers","volume":"31","author":"Hydbring","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1101\/gad.12.24.3777","article-title":"Polo-like kinases: A team that plays throughout mitosis","volume":"12","author":"Glover","year":"1998","journal-title":"Genes. Dev."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/ijc.24880","article-title":"Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer","volume":"126","author":"Shi","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/nar\/gkp002","article-title":"Functional links between clustered microRNAs: Suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer","volume":"37","author":"Kim","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/MCB.01977-07","article-title":"MicroRNAs in the miR-106b family regulate p21\/CDKN1A and promote cell cycle progression","volume":"28","author":"Ivanovska","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Lal, A., Kim, H.H., Abdelmohsen, K., Kuwano, Y., Pullmann, R., Srikantan, S., Subrahmanyam, R., Martindale, J.L., Yang, X., and Ahmed, F. (2008). p16(INK4a) translation suppressed by miR-24. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0001864"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/jcp.24368","article-title":"MicroRNA miR-24 promotes cell proliferation by targeting the CDKs inhibitors p27Kip1 and p16INK4a","volume":"228","author":"Giglio","year":"2013","journal-title":"J. Cell Physiol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1016\/j.febslet.2014.10.037","article-title":"Up-regulation of p21(WAF1\/CIP1) by miRNAs and its implications in bladder cancer cells","volume":"588","author":"Wang","year":"2014","journal-title":"FEBS Lett."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40659-016-0100-9","article-title":"Upregulation of MiR-196a promotes cell proliferation by downregulating p27(kip1) in laryngeal cancer","volume":"49","author":"Jin","year":"2016","journal-title":"Biol. Res."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1677\/ERC-07-0129","article-title":"MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle","volume":"14","author":"Visone","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.1073\/pnas.1002080107","article-title":"microRNA 17\/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling","volume":"107","author":"Yu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1038\/ncomms3812","article-title":"Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancer","volume":"4","author":"Yu","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.semcancer.2022.12.006","article-title":"CDK inhibitors from past to present: A new wave of cancer therapy","volume":"88","author":"Mughal","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa1607303","article-title":"Palbociclib and Letrozole in Advanced Breast Cancer","volume":"375","author":"Finn","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(15)00613-0","article-title":"Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): Final analysis of the multicentre, double-blind, phase 3 randomised controlled trial","volume":"17","author":"Cristofanilli","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMoa1609709","article-title":"Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer","volume":"375","author":"Hortobagyi","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/14656566.2018.1429407","article-title":"Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer","volume":"19","author":"Duso","year":"2018","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1200\/JCO.2017.73.7585","article-title":"MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+\/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy","volume":"35","author":"Sledge","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.1158\/1078-0432.CCR-13-1675","article-title":"Dual CDK4\/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma","volume":"19","author":"Rader","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ccr.2010.05.025","article-title":"A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma","volume":"18","author":"Puyol","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/bcr2419","article-title":"PD 0332991, a selective cyclin D kinase 4\/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro","volume":"11","author":"Finn","year":"2009","journal-title":"Breast Cancer Res."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13045-015-0194-5","article-title":"Palbociclib: A first-in-class CDK4\/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer","volume":"8","author":"Lu","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1158\/1535-7163.1427.3.11","article-title":"Specific inhibition of cyclin-dependent kinase 4\/6 by PD 0332991 and associated antitumor activity in human tumor xenografts","volume":"3","author":"Fry","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11060-012-1000-7","article-title":"Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells","volume":"111","author":"Whiteway","year":"2013","journal-title":"J. Neurooncol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/1060028018817904","article-title":"Ribociclib in HR+\/HER2\u2212 Advanced or Metastatic Breast Cancer Patients","volume":"53","author":"Rascon","year":"2019","journal-title":"Ann. Pharmacother."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-16-2653","article-title":"Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4\/6 Inhibition in ER-Positive Breast Cancer","volume":"77","author":"Jansen","year":"2017","journal-title":"Cancer Res."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bcp.2016.10.015","article-title":"Effect of abemaciclib (LY2835219) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo","volume":"124","author":"Wu","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/annonc\/mdy155","article-title":"Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer","volume":"29","author":"Hortobagyi","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1200\/JCO.2017.75.6155","article-title":"MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer","volume":"35","author":"Goetz","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41523-018-0097-z","article-title":"MONARCH 3 final PFS: A randomized study of abemaciclib as initial therapy for advanced breast cancer","volume":"5","author":"Johnston","year":"2019","journal-title":"NPJ Breast Cancer"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1470-2045(19)30804-6","article-title":"CDK4\/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: A US Food and Drug Administration pooled analysis","volume":"21","author":"Gao","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S1470-2045(21)00472-1","article-title":"Overall survival in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer treated with a cyclin-dependent kinase 4\/6 inhibitor plus fulvestrant: A US Food and Drug Administration pooled analysis","volume":"22","author":"Gao","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.thromres.2021.11.009","article-title":"Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4\/6 inhibitors: A systematic review and meta-analysis","volume":"208","author":"Bolzacchini","year":"2021","journal-title":"Thromb. Res."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/ijc.32020","article-title":"Molecular mechanisms of resistance to CDK4\/6 inhibitors in breast cancer: A review","volume":"145","author":"Pandey","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3389\/fonc.2019.00666","article-title":"Mechanisms of Resistance to CDK4\/6 Inhibitors: Potential Implications and Biomarkers for Clinical Practice","volume":"9","author":"McCartney","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1038\/s41467-020-16170-3","article-title":"Acquired resistance to combined BET and CDK4\/6 inhibition in triple-negative breast cancer","volume":"11","author":"Ge","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1158\/2159-8290.CD-20-1726","article-title":"INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4\/6 Kinase Inhibitors","volume":"12","author":"Li","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1158\/1078-0432.CCR-11-0244","article-title":"Early G\u2081 cyclin-dependent kinases as prognostic markers and potential therapeutic targets in esophageal adenocarcinoma","volume":"17","author":"Ismail","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4161\/cc.21195","article-title":"Therapeutic response to CDK4\/6 inhibition in breast cancer defined by ex vivo analyses of human tumors","volume":"11","author":"Dean","year":"2012","journal-title":"Cell Cycle"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1038\/onc.2010.154","article-title":"Therapeutic CDK4\/6 inhibition in breast cancer: Key mechanisms of response and failure","volume":"29","author":"Dean","year":"2010","journal-title":"Oncogene"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1158\/0008-5472.CAN-13-2923","article-title":"CDK4\/6 and IGF1 receptor inhibitors synergize to suppress the growth of p16INK4A-deficient pancreatic cancers","volume":"74","author":"Heilmann","year":"2014","journal-title":"Cancer Res."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/annonc\/mdx784","article-title":"Polyclonal RB1 mutations and acquired resistance to CDK 4\/6 inhibitors in patients with metastatic breast cancer","volume":"29","author":"Condorelli","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1200\/JCO.19.00090","article-title":"Cyclin E mRNA: Assessing Cyclin-Dependent Kinase (CDK) Activation State to Elucidate Breast Cancer Resistance to CDK4\/6 Inhibitors","volume":"37","author":"Chandarlapaty","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1038\/onc.2016.379","article-title":"Acquired CDK6 amplification promotes breast cancer resistance to CDK4\/6 inhibitors and loss of ER signaling and dependence","volume":"36","author":"Yang","year":"2017","journal-title":"Oncogene"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2018.04.037","article-title":"Cyclin E overexpression confers resistance to the CDK4\/6 specific inhibitor palbociclib in gastric cancer cells","volume":"430","author":"Min","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41698-022-00311-6","article-title":"Co-targeting CDK2 and CDK4\/6 overcomes resistance to aromatase and CDK4\/6 inhibitors in ER+ breast cancer","volume":"6","author":"Alves","year":"2022","journal-title":"NPJ Precis. Oncol."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1158\/2159-8290.CD-16-0095","article-title":"Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors","volume":"6","author":"Patnaik","year":"2016","journal-title":"Cancer Discov."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1158\/1078-0432.CCR-11-0509","article-title":"Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4\/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer","volume":"18","author":"Flaherty","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1093\/emboj\/18.22.6415","article-title":"Constitutive silencing of IFN-beta promoter is mediated by NRF (NF-kappaB-repressing factor), a nuclear inhibitor of NF-kappaB","volume":"18","author":"Nourbakhsh","year":"1999","journal-title":"EMBO J."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","article-title":"An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients","volume":"123","author":"Lanczky","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/0008-5472.CAN-15-0728","article-title":"Early Adaptation and Acquired Resistance to CDK4\/6 Inhibition in Estrogen Receptor-Positive Breast Cancer","volume":"76","author":"Palafox","year":"2016","journal-title":"Cancer Res."},{"key":"ref_281","doi-asserted-by":"crossref","unstructured":"Kruer, T.L., Dougherty, S.M., Reynolds, L., Long, E., de Silva, T., Lockwood, W.W., and Clem, B.F. (2016). Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166363"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"590813","DOI":"10.3389\/fonc.2020.590813","article-title":"Overexpression of miRNA-3613-3p Enhances the Sensitivity of Triple Negative Breast Cancer to CDK4\/6 Inhibitor Palbociclib","volume":"10","author":"Yu","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1158\/0008-5472.CAN-19-1793","article-title":"Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4\/6 Inhibitors in Luminal Breast Cancer","volume":"80","author":"Citron","year":"2020","journal-title":"Cancer Res."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fgene.2018.00174","article-title":"Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4\/6 and PIK3CA Inhibitors","volume":"9","author":"Baldassari","year":"2018","journal-title":"Front. Genet."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.celrep.2019.02.023","article-title":"MicroRNA-Mediated Suppression of the TGF-\u03b2 Pathway Confers Transmissible and Reversible CDK4\/6 Inhibitor Resistance","volume":"26","author":"Cornell","year":"2019","journal-title":"Cell Rep."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.bbrc.2017.12.013","article-title":"Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p","volume":"495","author":"Kong","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_287","first-page":"6838","article-title":"LncRNA SNHG15 promotes proliferation and migration of lung cancer via targeting microRNA-211-3p","volume":"22","author":"Cui","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_288","first-page":"1720","article-title":"Long noncoding RNA SNHG15, a potential prognostic biomarker for hepatocellular carcinoma","volume":"20","author":"Zhang","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"180158","DOI":"10.1038\/sdata.2018.158","article-title":"The REMBRANDT study, a large collection of genomic data from brain cancer patients","volume":"5","author":"Gusev","year":"2018","journal-title":"Sci. Data"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1750-3639.2009.00356.x","article-title":"Genomic landscape of meningiomas","volume":"20","author":"Lee","year":"2010","journal-title":"Brain Pathol."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1038\/onc.2011.193","article-title":"microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer","volume":"30","author":"Braconi","year":"2011","journal-title":"Oncogene"},{"key":"ref_292","doi-asserted-by":"crossref","unstructured":"Lu, K.H., Li, W., Liu, X.H., Sun, M., Zhang, M.L., Wu, W.Q., Xie, W.P., and Hou, Y.Y. (2013). Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-461"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/jcb.24055","article-title":"Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation","volume":"113","author":"Wang","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-09-3885","article-title":"Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression","volume":"70","author":"Zhang","year":"2010","journal-title":"Cancer Res."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"24731","DOI":"10.1074\/jbc.M702029200","article-title":"Activation of p53 by MEG3 non-coding RNA","volume":"282","author":"Zhou","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1038\/ncomms8743","article-title":"MEG3 long noncoding RNA regulates the TGF-\u03b2 pathway genes through formation of RNA-DNA triplex structures","volume":"6","author":"Mondal","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_297","doi-asserted-by":"crossref","unstructured":"Liu, J., Wan, L., Lu, K., Sun, M., Pan, X., Zhang, P., Lu, B., Liu, G., and Wang, Z. (2015). The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0114586"},{"key":"ref_298","doi-asserted-by":"crossref","unstructured":"Huang, Q., Shen, Y.J., Hsueh, C.Y., Guo, Y., Zhang, Y.F., Li, J.Y., and Zhou, L. (2021). miR-17-5p drives G2\/M-phase accumulation by directly targeting CCNG2 and is related to recurrence of head and neck squamous cell carcinoma. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08812-6"},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41556-018-0249-2","article-title":"The dynamic nature of senescence in cancer","volume":"21","author":"Lee","year":"2019","journal-title":"Nat. Cell. Biol."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41418-020-00648-0","article-title":"Ubiquitin signaling in cell cycle control and tumorigenesis","volume":"28","author":"Dang","year":"2021","journal-title":"Cell. Death Differ."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pharmthera.2013.01.011","article-title":"Targeting cell cycle regulation in cancer therapy","volume":"138","author":"Miranda","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_302","first-page":"917","article-title":"MiR-369-3p inhibits tumorigenesis of hepatocellular carcinoma by binding to PAX6","volume":"34","author":"Xu","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"3695848","DOI":"10.1155\/2022\/3695848","article-title":"Human Amniotic Fluid Mesenchymal Stem Cell-Derived Exosomes Inhibit Apoptosis in Ovarian Granulosa Cell via miR-369-3p\/YAF2\/PDCD5\/p53 Pathway","volume":"2022","author":"Geng","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1126\/science.1149460","article-title":"Switching from repression to activation: microRNAs can up-regulate translation","volume":"318","author":"Vasudevan","year":"2007","journal-title":"Science"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nmeth.1504","article-title":"A quantitative targeted proteomics approach to validate predicted microRNA targets in C. elegans","volume":"7","author":"Jovanovic","year":"2010","journal-title":"Nat. Methods"},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.molcel.2004.05.025","article-title":"Targeted proteomic study of the cyclin-Cdk module","volume":"14","author":"Archambault","year":"2004","journal-title":"Mol. Cell"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"8060","DOI":"10.1093\/nar\/gkac611","article-title":"LncRNA CTBP1-DT-encoded microprotein DDUP sustains DNA damage response signalling to trigger dual DNA repair mechanisms","volume":"50","author":"Yu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"104602","DOI":"10.1016\/j.yexmp.2021.104602","article-title":"LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin","volume":"123","author":"Taheri","year":"2021","journal-title":"Exp. Mol. Pathol."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1158\/0008-5472.CAN-16-2355","article-title":"Micellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer","volume":"77","author":"Wen","year":"2017","journal-title":"Cancer Res."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-020-01171-z","article-title":"Role of non-coding RNAs and RNA modifiers in cancer therapy resistance","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","article-title":"MicroRNAs in cancer","volume":"4","author":"Lee","year":"2009","journal-title":"Annu. Rev. Pathol."},{"key":"ref_312","doi-asserted-by":"crossref","unstructured":"Bencivenga, D., Stampone, E., Vastante, A., Barahmeh, M., Della Ragione, F., and Borriello, A. (2022). An Unanticipated Modulation of Cyclin-Dependent Kinase Inhibitors: The Role of Long Non-Coding RNAs. Cells, 11.","DOI":"10.3390\/cells11081346"},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fgene.2012.00120","article-title":"miR-34\u2014A microRNA replacement therapy is headed to the clinic","volume":"3","author":"Bader","year":"2012","journal-title":"Front. Genet."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/IJN.S122171","article-title":"Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells","volume":"12","author":"Rui","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature04303","article-title":"Silencing of microRNAs in vivo with \u2018antagomirs\u2019","volume":"438","author":"Rajewsky","year":"2005","journal-title":"Nature"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/10\/8939\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:37:28Z","timestamp":1760125048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/10\/8939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":316,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["ijms24108939"],"URL":"https:\/\/doi.org\/10.3390\/ijms24108939","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]}}}